BioPharm News

Feb 04, 2010
Watson Pharmaceuticals has acquired Eden Biodesign for $15 million.
Feb 01, 2010
By BioPharm International Editors
The US Food and Drug Administration is requesting $4.03 billion to promote and protect public health as part of the President's fiscal year 2011 budget?a 23% increase over the agency?s current $3.28 billion budget.
Jan 29, 2010
London-based pharmaceutical company AstraZeneca plans to slash 8,000 jobs, or 12% of its work force, by 2014 to cut costs.
Jan 15, 2010
BioPharm International
By BioPharm International Editors
Sanofi Pasteur, the vaccines division of the Sanofi-Aventis Group, has signed an agreement with KaloBios Pharmaceuticals for the development of humanized antibody fragment to both treat and prevent Pseudomonas aeruginosa infections.
Jan 15, 2010
BioPharm International
By BioPharm International Editors
BiondVax Pharmaceuticals Ltd, an Israeli biopharmaceutical company, has completed Phase 1-2 clinical trials of its Multimeric-001 universal flu vaccine.
Jan 15, 2010
BioPharm International
The results of BioPharm International's fourth annual salary survey, conducted in the fall of 2009, shows that women lag behind their male counterparts.
Jan 15, 2010
BioPharm International
By BioPharm International Editors
The US Food and Drug Administration has approved Genentech's Actemra (tocilizumab) to treat adults with moderate to severe rheumatoid arthritis who have not adequately responded to or cannot tolerate other approved therapies for rheumatoid arthritis.
Jan 15, 2010
BioPharm International
By BioPharm International Editors
Shire plc (Cambridge, MA) has submitted a biologics license application (BLA) with the FDA for Replagal (agalsidase alfa), its enzyme replacement therapy for Fabry disease.
Jan 15, 2010
BioPharm International
By BioPharm International Editors
The US Food and Drug Administration has approved Sanofi Pasteur's Fluzone High-Dose, an inactivated influenza virus vaccine for people ages 65 years and older, to prevent disease caused by influenza virus subtypes A and B.
Jan 12, 2010
BioPharm International
By BioPharm International Editors
native1_300x100
lorem ipsum